<DOC>
	<DOCNO>NCT00014313</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy treat patient metastatic Ewing 's sarcoma primitive neuroectodermal tumor .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Metastatic Ewing 's Sarcoma Primitive Neuroectodermal Tumor</brief_title>
	<detailed_description>OBJECTIVES : - Determine activity cisplatin etoposide term response patient metastatic Ewing 's sarcoma primitive neuroectodermal tumor . - Assess bone marrow kidney toxicity regimen patient . OUTLINE : This multicenter study . Patients receive cisplatin IV 3 hour day 1 , 8 , 15 , 29 , 36 , 43 oral etoposide daily day 1-15 29-43 absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 21-45 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm Ewing 's family tumor characterize following : Positive MIC2 immunohistochemistry OR Evidence chromosomal translocation involve EWS gene conventional cytogenetics ( 11 ; 22 ) translocation variant OR Demonstration EWS/FLI1 EWS/ERG gene fusion PCR FISH Metastases outside lung pleura At least 1 measurable lesion outside previously irradiate area No symptomatic know CNS metastases PATIENT CHARACTERISTICS : Age : 15 65 Performance status : WHO 02 Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 3 mg/dL Albumin great 2.5 g/dL Renal : Creatinine le 1.2 mg/dL Creatinine clearance great 70 mL/min Cardiovascular : No history uncontrolled cardiovascular disease Other : No severe medical illness , include psychosis No prior primary malignancy except adequately treat carcinoma situ cervix basal cell skin cancer Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
</DOC>